:: KONGPOSH Publications - Did You Know ::

HOME CONTACT BACK

INSTRUCTIONS TO AUTHORS

'The Pharma Review®' is a bi-monthly pharma journal covering all aspects of the noble profession of pharmacy. 'The Pharma Review®' invites original contributions from all the Pharma and allied medical and paramedical healthcare professionals from the industry and the academia who are willing to participate in the promotion and upliftment of the pharmacy profession. We invite review/research articles from our readers. Authors are requested to carefully read and understand the following instructions and comply with the style of The Pharma Review® before preparing and sending the manuscripts.

Review Articles

Review articles are written by researchers of considerable experience in the field concerned. The author should review the recent trend or advances in that field in the light of his own work. Reviews should be based on assimilation of data from various sources for the purpose of establishing a new concept. The review should be well structured starting with introduction and ending with conclusion. The major portion of above articles should deal with the upto-date developments in the field in the last 3-5 years. Other headings and sub-headings depend upon the nature and content of the review. There should not be more than 2 tablets, 2 charts/graphs, or 2 diagrams (in total, not more than 4 of any of them) in the review article. Abstract should not be more than 200 words and total length of article should be in between 2500 to 3000 words. In exceptional cases, more lengthy articles can also be considered. Small articles can be published as viewpoint.

Research & Development Articles

This section invites original research work done in the pharmaceutics, analytical/pharmaceutical chemistry, pharmacognosy, pharmacology, development of new concepts/methods or procedures which have a technological advancement or definite advantages over the other established procedures. A uniform pattern mentioned below is to be strictly adhered to. Total length of research articles should be between 1500 to 2000 words not exceeding 4 pages in approx A4 size including text, diagrams, tables and references.

All R&D articles will be will be published under the Research & Development Section of The Pharma Review journal and will carry a nominal publishing charge of Rs. 1500/- per article, payable along with the manuscript by Bankers Cheque / DD in favour of Kongposh Publications Pvt. Ltd.

The Research article should be arranged into the following sections:

1) Title page: It should carry the title, author’s names and their affiliations, running title, address for correspondence including e-mail address.

2) Abstract and Key words: It must start on a new page carrying the following information: (a) Title (without authors’ names & affiliations), (b) Abstract, (c) Key words. The abstract should not exceed 250 words excluding the title and the key words. The abstract must be concise, clear and informative

3) Introduction: It should start on a new page. This section must introduce the subject and briefly say how the idea for research originated. Give a concise background of the study. Do not review literature extensively but provide the most recent work that has a direct bearing on the subject. Justification for research aims and objectives must be clearly mentioned without any ambiguity. The purpose of the study should be stated at the end.

4) Materials and Methods: This section should deal with the materials used and the methodology - how the work was carried out. The procedure adopted should be described in sufficient detail to allow the experiment to be interpreted and repeated by the readers, if necessary. The number of subjects, the number of groups studied, the study design, sources of drugs with dosage regimen or instruments used, statistical methods and ethical aspects must be mentioned under the section. The methodology - the data collection procedure - must be described in sufficient detail. The details of statistical tests used and the level of significance should be stated. If more than one test is used it is important to indicate which groups and parameters have been subjected to which test.

‘The Pharma Review®’ insists on ethical practices in both animal experimentation and clinical studies. Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA (animal) and ICMR guidelines (human). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.

5) Results: The results should be stated concisely without comments. It should be presented in logical sequence in the text with appropriate reference to tables and/or figures. The data given in tables or figures should not be repeated in the text. The same data should not be presented in both tabular and graphic forms. Simple data may be given in the text itself instead of figures or tables. Avoid discussions and conclusions in the results section.

6) Discussion: This section should deal with the interpretation, rather than recapitulation of results. It is important to discuss the new and significant observations in the light of previous work. Discuss also the weaknesses or pitfalls in the study. New hypotheses or recommendations can be put forth. Avoid unqualified statements and conclusions not completely supported by the data. Repetition of information given under Introduction and Results should be avoided. Conclusions must be drawn considering the strengths and weaknesses of the study.

7) Acknowledgements: At the end of the text please add (a) contributions that need acknowledging but do not justify authorship, such as general support by a Departmental Chair, (b) acknowledgements of technical help, and (c) acknowledgements of financial and material support, which should specify the nature of the support and relationships that may pose a conflict of interest.

8) References: It should begin on a new page. The number of references should normally be restricted to a maximum of 25 for a full paper. Majority of them should preferably be of articles published in the last 5-10 years. Avoid citing abstracts as references. Papers which have been submitted and accepted but not yet published may be included in the list of references with the name of the journal and indicated as “In press”. The “unpublished observations” and “personal communications” may not be used as references but may be inserted (in parentheses) in the text. References are to be cited in the text by superscribed number and should be in the order in which they appear. The references must be verified by the author(s) against the original documents. The list of references should be typed double spaced following the Vancouver style. The Journal will now follow uniform requirements for manuscripts submitted to Bio-Medical journals (New England Journal Medicine 1997; 336: 309–15) which are international standards designed to provide authors with a single format that can be followed in preparing a manuscript.

9) Tables: Each table must be self-explanatory and presented in such a way that they are easily understandable without referring to the text. It should be typed with double spacing and numbered consecutively with Arabic numerals. Provide a short descriptive caption above each table with foot notes and/or explanations underneath. The number of observations, subjects and the units of numerical figures must be given. It is also important to mention whether the given values are mean, median, mean ± SD or mean ± SEM. All significant results must be indicated using asterisks, rows and columns properly aligned. Appropriate positions for the tables within the text may be indicated. The tables should be serially numbered, should be accompanied with a short self explanatory caption, Mean ± SD or Mean ± SEM given, statistical significance of groups indicated by asterisks or other markers, P values given, if any.

10) Figures: Each figure must be numbered and a short descriptive caption must be provided. All significant results should be indicated using asterisks.

Authors must be careful when they reproduce text, tables or illustrations from other sources. Plagiarism will be viewed seriously.

-copying verbatim text, tables or illustrations from any source (journal article, book, monographs, thesis, Internet/any electronic media or any other published or unpublished material) and passing it as ones own is considered plagiarism whether or not a reference to the copied portion is given.

-listing the source of copied material under 'References' does not absolve the authors of plagiarism.

-if a few lines of text are to be reproduced from any source, 'the author' and 'the source' must be clearly indicated in the text. The reproduced lines must be in italics and given within quotes. If it is a paragraph it must be slightly indented also. To reproduce large portions of text, permission from the copyright owner(s) must be obtained and submitted to the IJP.

General Instructions

1. Contributions should be made keeping in view the current trends in the pharmaceutical industry and the work should have relevance in the current day.

2. The manuscript should be in MS word format on a fresh floppy / CD bearing proper label. Incomplete or improperly prepared manuscripts will be returned to the author(s) without editorial review. Copy can also be sent to us by email at kongposhpub@gamil.com or info@kppub.com

3. The editor reserves rights to edit, elaborate, or reduce the content submitted by the contributors.

4. Any article accepted for publication/published in the TPR will be the copyright of the journal. The journal has the right to publish the accepted articles in any media (print, electronic or any other) any number of times.

5. All contributions should be marked to "The Editor" and sent to the company’s Delhi address..

6. Manuscripts for publication will be considered on their individual merits. All manuscripts will be subjected to peer review. Comments, if any by the editorial board will be forwarded to the authors for further action.

AUTHORSHIP AND RESPONSIBILITIES

Authors should be ready to take public responsibility for the content of the paper.

All the authors in a manuscript are responsible for the technical information communicated. For this reason it is necessary that all authors must read and approve the final version of the manuscript before forwarding the same.

The Pharma Review® - The Umbrella Magazine of the Pharma industry is an ideal platform provided to the members of the pharmaceutical industry to express their views and exchange ideas to help in the upliftment of the pharmacy profession.